25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

C4X (Onxeo SA) Stock Analysis
Buy, Hold or Sell?

Let's analyze Onxeo SA together

I guess you are interested in Onxeo SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Onxeo SA’s Financial Insights
  • 📈 Technical Analysis (TA) – Onxeo SA’s Price Targets

I'm going to help you getting a better view of Onxeo SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Onxeo SA

I send you an email if I find something interesting about Onxeo SA.

1. Quick Overview

1.1. Quick analysis of Onxeo SA (30 sec.)










1.2. What can you expect buying and holding a share of Onxeo SA? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€-0.02
Expected worth in 1 year
€-0.21
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
€-0.19
Return On Investment
-114.5%

For what price can you sell your share?

Current Price per Share
€0.17
Expected price per share
€0.119 - €
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Onxeo SA (5 min.)




Live pricePrice per Share (EOD)
€0.17
Intrinsic Value Per Share
€-0.31 - €-0.28
Total Value Per Share
€-0.32 - €-0.30

2.2. Growth of Onxeo SA (5 min.)




Is Onxeo SA growing?

Current yearPrevious yearGrowGrow %
How rich?-$9.6m$17.2m-$26.8m-279.1%

How much money is Onxeo SA making?

Current yearPrevious yearGrowGrow %
Making money-$27.8m-$23.6m-$4.1m-15.0%
Net Profit Margin-1,334.7%-1,130.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Onxeo SA (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Onxeo SA?

Welcome investor! Onxeo SA's management wants to use your money to grow the business. In return you get a share of Onxeo SA.

First you should know what it really means to hold a share of Onxeo SA. And how you can make/lose money.

Speculation

The Price per Share of Onxeo SA is €0.165. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Onxeo SA.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Onxeo SA, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-0.02. Based on the TTM, the Book Value Change Per Share is €-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Onxeo SA.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.06-34.5%-0.06-34.5%-0.05-29.3%-0.05-30.7%-0.03-19.8%-0.05-30.7%
Usd Book Value Change Per Share-0.05-33.3%-0.05-33.3%-0.02-10.8%-0.03-19.8%-0.01-7.3%-0.03-18.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-33.3%-0.05-33.3%-0.02-10.8%-0.03-19.8%-0.01-7.3%-0.03-18.8%
Usd Price Per Share0.10-0.10-0.18-0.14-0.33-1.16-
Price to Earnings Ratio-1.69--1.69--3.64--2.78-50.89-4.97-
Price-to-Total Gains Ratio-1.75--1.75--9.91--5.73-12.21--28.22-
Price to Book Ratio-4.90--4.90-5.00-0.92-3.98-8.40-
Price-to-Total Gains Ratio-1.75--1.75--9.91--5.73-12.21--28.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1918125
Number of shares5213
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.05-0.01
Usd Total Gains Per Share-0.05-0.01
Gains per Quarter (5213 shares)-286.28-63.19
Gains per Year (5213 shares)-1,145.11-252.77
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1145-11550-253-263
20-2290-23000-506-516
30-3435-34450-758-769
40-4580-45900-1011-1022
50-5726-57350-1264-1275
60-6871-68800-1517-1528
70-8016-80250-1769-1781
80-9161-91700-2022-2034
90-10306-103150-2275-2287
100-11451-114600-2528-2540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.09.00.010.0%1.011.00.08.3%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%2.08.00.020.0%4.08.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.012.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%2.08.00.020.0%4.08.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Onxeo SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.047-0.0470%-0.015-68%-0.028-40%-0.010-78%-0.027-44%
Book Value Per Share---0.017-0.0170%0.030-156%0.020-186%0.037-146%0.082-121%
Current Ratio--0.2490.2490%1.168-79%1.432-83%2.479-90%2.513-90%
Debt To Asset Ratio--1.4611.4610%0.580+152%0.841+74%0.656+123%0.492+197%
Debt To Equity Ratio----0%1.383-100%0.772-100%0.706-100%0.626-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--14291185.67614291185.6760%53517798.914-73%35361583.793-60%118090949.192-88%462976247.901-97%
Eps---0.049-0.0490%-0.042-15%-0.044-11%-0.028-43%-0.044-11%
Ev To Sales Ratio--7.9717.9710%29.732-73%21.409-63%56.039-86%121.833-93%
Free Cash Flow Per Share---0.026-0.0260%-0.036+38%-0.027+5%-0.022-16%-0.026-1%
Free Cash Flow To Equity Per Share---0.026-0.0260%-0.036+38%-0.027+5%-0.014-46%-0.015-43%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.281----------
Intrinsic Value_10Y_min---0.305----------
Intrinsic Value_1Y_max---0.023----------
Intrinsic Value_1Y_min---0.029----------
Intrinsic Value_3Y_max---0.074----------
Intrinsic Value_3Y_min---0.088----------
Intrinsic Value_5Y_max---0.129----------
Intrinsic Value_5Y_min---0.150----------
Market Cap80579681.985+50%40485185.67640485185.6760%73986798.914-45%57854583.793-30%139104949.192-71%485875947.901-92%
Net Profit Margin---13.347-13.3470%-11.302-15%-12.735-5%-7.811-41%-6.537-51%
Operating Margin----0%-0%-0%-1.1550%-2.3520%
Operating Ratio--10.48210.4820%11.881-12%11.860-12%8.728+20%7.394+42%
Pb Ratio-9.750-99%-4.898-4.8980%4.997-198%0.917-634%3.983-223%8.399-158%
Pe Ratio-3.367-99%-1.692-1.6920%-3.637+115%-2.783+65%50.885-103%4.972-134%
Price Per Share0.165+50%0.0830.0830%0.152-45%0.118-30%0.285-71%0.995-92%
Price To Free Cash Flow Ratio-6.306-99%-3.168-3.1680%-4.210+33%-4.443+40%-20.695+553%-19.042+501%
Price To Total Gains Ratio-3.493-99%-1.755-1.7550%-9.911+465%-5.734+227%12.213-114%-28.220+1508%
Quick Ratio--0.0940.0940%0.170-45%0.157-40%0.555-83%0.753-88%
Return On Assets---1.335-1.3350%-0.577-57%-0.789-41%-0.491-63%-0.459-66%
Return On Equity----0%-1.3740%-0.7510%-0.4790%-0.6180%
Total Gains Per Share---0.047-0.0470%-0.015-68%-0.028-40%-0.010-78%-0.027-44%
Usd Book Value---9608062.500-9608062.5000%17210812.500-156%11163875.000-186%21108210.000-146%46517205.000-121%
Usd Book Value Change Per Share---0.055-0.0550%-0.018-68%-0.033-40%-0.012-78%-0.031-44%
Usd Book Value Per Share---0.020-0.0200%0.035-156%0.023-186%0.043-146%0.095-121%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--16613503.34816613503.3480%62214441.237-73%41107841.159-60%137280728.435-88%538209888.185-97%
Usd Eps---0.057-0.0570%-0.048-15%-0.051-11%-0.033-43%-0.051-11%
Usd Free Cash Flow---14855587.500-14855587.5000%-20429775.000+38%-15610050.000+5%-12506640.000-16%-11761477.500-21%
Usd Free Cash Flow Per Share---0.030-0.0300%-0.042+38%-0.032+5%-0.026-16%-0.030-1%
Usd Free Cash Flow To Equity Per Share---0.030-0.0300%-0.042+38%-0.032+5%-0.016-46%-0.017-43%
Usd Market Cap93673880.308+50%47064028.34847064028.3480%86009653.737-45%67255953.659-30%161709503.435-71%564830789.435-92%
Usd Price Per Share0.192+50%0.0960.0960%0.176-45%0.138-30%0.331-71%1.157-92%
Usd Profit---27819787.500-27819787.5000%-23649900.000-15%-24736837.500-11%-15969262.500-43%-24756948.750-11%
Usd Revenue--2084362.5002084362.5000%2092500.0000%1951450.000+7%2528205.000-18%4498758.750-54%
Usd Total Gains Per Share---0.055-0.0550%-0.018-68%-0.033-40%-0.012-78%-0.031-44%
 EOD+6 -2MRQTTM+0 -0YOY+10 -243Y+11 -235Y+4 -3010Y+5 -29

3.3 Fundamental Score

Let's check the fundamental score of Onxeo SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.367
Price to Book Ratio (EOD)Between0-1-9.750
Net Profit Margin (MRQ)Greater than0-13.347
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.094
Current Ratio (MRQ)Greater than10.249
Debt to Asset Ratio (MRQ)Less than11.461
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.335
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Onxeo SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.233
Ma 20Greater thanMa 500.101
Ma 50Greater thanMa 1000.075
Ma 100Greater thanMa 2000.067
OpenGreater thanClose0.102
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Onxeo SA

Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, designs and develops novel and first-in-class DNA-decoy therapies targeting proteins in tumors and inflammatory disease processes. The company develops developing VIO-01, which is in Phase 1/2 of the VIO-01 clinical study, a Pan-DDR DNA decoy targeting multiple proteins and repair pathways in preclinical development; and PlatON, generates DecoyTAC combining DNA decoy molecules capable of cell penetration with a linker+E3 ligand. It also develops V-body platform, a bispecifics, ADCs, CAR-T, and V-body-oligonucleotide conjugates. The company was formerly known as Onxeo SA and changed its name to Valerio Therapeutics Société anonyme in June 2023. Valerio Therapeutics Société anonyme was incorporated in 1997 and is headquartered in Paris, France.

Fundamental data was last updated by Penke on 2025-11-03 03:47:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Onxeo SA earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Onxeo SA to the Biotechnology industry mean.
  • A Net Profit Margin of -1,334.7% means that €-13.35 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Onxeo SA:

  • The MRQ is -1,334.7%. The company is making a huge loss. -2
  • The TTM is -1,334.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,334.7%TTM-1,334.7%0.0%
TTM-1,334.7%YOY-1,130.2%-204.5%
TTM-1,334.7%5Y-781.1%-553.6%
5Y-781.1%10Y-653.7%-127.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,334.7%-68.9%-1,265.8%
TTM-1,334.7%-160.6%-1,174.1%
YOY-1,130.2%-189.1%-941.1%
3Y-1,273.5%-259.8%-1,013.7%
5Y-781.1%-340.9%-440.2%
10Y-653.7%-469.0%-184.7%
4.3.1.2. Return on Assets

Shows how efficient Onxeo SA is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Onxeo SA to the Biotechnology industry mean.
  • -133.5% Return on Assets means that Onxeo SA generated €-1.33 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Onxeo SA:

  • The MRQ is -133.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -133.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-133.5%TTM-133.5%0.0%
TTM-133.5%YOY-57.7%-75.8%
TTM-133.5%5Y-49.1%-84.4%
5Y-49.1%10Y-45.9%-3.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-133.5%-11.5%-122.0%
TTM-133.5%-11.4%-122.1%
YOY-57.7%-11.2%-46.5%
3Y-78.9%-12.0%-66.9%
5Y-49.1%-11.7%-37.4%
10Y-45.9%-13.6%-32.3%
4.3.1.3. Return on Equity

Shows how efficient Onxeo SA is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Onxeo SA to the Biotechnology industry mean.
  • 0.0% Return on Equity means Onxeo SA generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Onxeo SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-137.4%+137.4%
TTM-5Y-47.9%+47.9%
5Y-47.9%10Y-61.8%+13.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.3%+13.3%
TTM--14.4%+14.4%
YOY-137.4%-15.0%-122.4%
3Y-75.1%-16.6%-58.5%
5Y-47.9%-16.8%-31.1%
10Y-61.8%-19.4%-42.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Onxeo SA.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Onxeo SA is operating .

  • Measures how much profit Onxeo SA makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Onxeo SA to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Onxeo SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-115.5%+115.5%
5Y-115.5%10Y-235.2%+119.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--148.9%+148.9%
TTM--255.1%+255.1%
YOY--252.1%+252.1%
3Y--245.0%+245.0%
5Y-115.5%-332.9%+217.4%
10Y-235.2%-499.4%+264.2%
4.3.2.2. Operating Ratio

Measures how efficient Onxeo SA is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 10.48 means that the operating costs are €10.48 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Onxeo SA:

  • The MRQ is 10.482. The company is inefficient in keeping operating costs low. -1
  • The TTM is 10.482. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ10.482TTM10.4820.000
TTM10.482YOY11.881-1.399
TTM10.4825Y8.728+1.754
5Y8.72810Y7.394+1.334
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.4821.873+8.609
TTM10.4822.648+7.834
YOY11.8812.832+9.049
3Y11.8603.539+8.321
5Y8.7284.562+4.166
10Y7.3946.341+1.053
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Onxeo SA.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Onxeo SA is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.25 means the company has €0.25 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Onxeo SA:

  • The MRQ is 0.249. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.249. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.249TTM0.2490.000
TTM0.249YOY1.168-0.918
TTM0.2495Y2.479-2.230
5Y2.47910Y2.513-0.034
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2493.272-3.023
TTM0.2493.518-3.269
YOY1.1683.924-2.756
3Y1.4324.372-2.940
5Y2.4795.618-3.139
10Y2.5135.974-3.461
4.4.3.2. Quick Ratio

Measures if Onxeo SA is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Onxeo SA to the Biotechnology industry mean.
  • A Quick Ratio of 0.09 means the company can pay off €0.09 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Onxeo SA:

  • The MRQ is 0.094. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.094. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.094TTM0.0940.000
TTM0.094YOY0.170-0.076
TTM0.0945Y0.555-0.461
5Y0.55510Y0.753-0.198
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0942.770-2.676
TTM0.0943.130-3.036
YOY0.1703.786-3.616
3Y0.1574.321-4.164
5Y0.5555.648-5.093
10Y0.7536.365-5.612
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Onxeo SA.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Onxeo SA assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Onxeo SA to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.46 means that Onxeo SA assets are financed with 146.1% credit (debt) and the remaining percentage (100% - 146.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Onxeo SA:

  • The MRQ is 1.461. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.461. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.461TTM1.4610.000
TTM1.461YOY0.580+0.881
TTM1.4615Y0.656+0.805
5Y0.65610Y0.492+0.164
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4610.355+1.106
TTM1.4610.364+1.097
YOY0.5800.334+0.246
3Y0.8410.353+0.488
5Y0.6560.351+0.305
10Y0.4920.380+0.112
4.5.4.2. Debt to Equity Ratio

Measures if Onxeo SA is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Onxeo SA to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Onxeo SA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.383-1.383
TTM-5Y0.706-0.706
5Y0.70610Y0.626+0.080
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.414-0.414
TTM-0.448-0.448
YOY1.3830.436+0.947
3Y0.7720.476+0.296
5Y0.7060.475+0.231
10Y0.6260.524+0.102
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Onxeo SA generates.

  • Above 15 is considered overpriced but always compare Onxeo SA to the Biotechnology industry mean.
  • A PE ratio of -1.69 means the investor is paying €-1.69 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Onxeo SA:

  • The EOD is -3.367. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.692. Based on the earnings, the company is expensive. -2
  • The TTM is -1.692. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.367MRQ-1.692-1.675
MRQ-1.692TTM-1.6920.000
TTM-1.692YOY-3.637+1.945
TTM-1.6925Y50.885-52.577
5Y50.88510Y4.972+45.914
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.367-2.496-0.871
MRQ-1.692-2.257+0.565
TTM-1.692-2.631+0.939
YOY-3.637-3.696+0.059
3Y-2.783-3.622+0.839
5Y50.885-5.772+56.657
10Y4.972-6.725+11.697
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Onxeo SA:

  • The EOD is -6.306. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.168. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.168. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.306MRQ-3.168-3.138
MRQ-3.168TTM-3.1680.000
TTM-3.168YOY-4.210+1.042
TTM-3.1685Y-20.695+17.527
5Y-20.69510Y-19.042-1.653
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.306-3.372-2.934
MRQ-3.168-2.975-0.193
TTM-3.168-3.679+0.511
YOY-4.210-4.286+0.076
3Y-4.443-5.330+0.887
5Y-20.695-8.219-12.476
10Y-19.042-9.647-9.395
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Onxeo SA is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -4.90 means the investor is paying €-4.90 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Onxeo SA:

  • The EOD is -9.750. Based on the equity, the company is expensive. -2
  • The MRQ is -4.898. Based on the equity, the company is expensive. -2
  • The TTM is -4.898. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.750MRQ-4.898-4.851
MRQ-4.898TTM-4.8980.000
TTM-4.898YOY4.997-9.896
TTM-4.8985Y3.983-8.881
5Y3.98310Y8.399-4.416
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.7502.350-12.100
MRQ-4.8982.140-7.038
TTM-4.8982.170-7.068
YOY4.9972.566+2.431
3Y0.9172.664-1.747
5Y3.9833.755+0.228
10Y8.3994.363+4.036
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-12-312021-12-312022-12-312023-12-312024-12-31
Total Stockholder Equity 29,0363,90632,942-10,67222,270-7,46514,805-23,735-8,930
Net Working Capital  17,1305,94023,070-9,64013,430-11,5651,865-15,633-13,768
Net Interest Income  -347-346-693-1,856-2,5492,511-38209171



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets17,929
Total Liabilities26,194
Total Stockholder Equity-8,930
 As reported
Total Liabilities 26,194
Total Stockholder Equity+ -8,930
Total Assets = 17,929

Assets

Total Assets17,929
Total Current Assets4,569
Long-term Assets13,361
Total Current Assets
Cash And Cash Equivalents 1,178
Net Receivables 1,724
Total Current Assets  (as reported)4,569
Total Current Assets  (calculated)2,902
+/- 1,667
Long-term Assets
Property Plant Equipment 1,172
Goodwill 11,968
Long-term Assets  (as reported)13,361
Long-term Assets  (calculated)13,140
+/- 221

Liabilities & Shareholders' Equity

Total Current Liabilities18,337
Long-term Liabilities7,857
Total Stockholder Equity-8,930
Total Current Liabilities
Short Long Term Debt 7,297
Accounts payable 5,247
Other Current Liabilities 3,128
Total Current Liabilities  (as reported)18,337
Total Current Liabilities  (calculated)15,672
+/- 2,665
Long-term Liabilities
Long term Debt 5,631
Capital Lease Obligations Min Short Term Debt507
Long-term Liabilities Other 1,739
Long-term Liabilities  (as reported)7,857
Long-term Liabilities  (calculated)7,877
+/- 20
Total Stockholder Equity
Total Stockholder Equity (as reported)-8,930
Total Stockholder Equity (calculated)0
+/- 8,930
Other
Capital Stock21,611
Common Stock Shares Outstanding 153,878
Net Debt 11,750
Net Invested Capital 3,998
Net Working Capital -13,768
Property Plant and Equipment Gross 6,173



6.3. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
17,732
151,999
129,235
125,100
78,073
63,250
37,629
46,506
53,063
43,086
35,274
17,929
17,92935,27443,08653,06346,50637,62963,25078,073125,100129,235151,99917,732
   > Total Current Assets 
16,432
62,946
41,696
36,868
29,962
20,376
11,284
23,177
30,133
20,579
12,995
4,569
4,56912,99520,57930,13323,17711,28420,37629,96236,86841,69662,94616,432
       Cash And Cash Equivalents 
3,972
57,227
28,486
23,941
14,277
11,253
5,708
14,523
17,887
14,586
6,818
1,178
1,1786,81814,58617,88714,5235,70811,25314,27723,94128,48657,2273,972
       Short-term Investments 
7,357
0
5,307
5,302
0
0
0
0
0
0
0
0
000000005,3025,30707,357
       Net Receivables 
4,416
4,950
7,158
6,500
15,655
7,904
5,315
6,654
8,526
1,473
1,889
1,724
1,7241,8891,4738,5266,6545,3157,90415,6556,5007,1584,9504,416
       Inventory 
3
65
106
184
30
47
64
0
0
0
0
0
00000644730184106653
       Other Current Assets 
0
-1
-1
1
0
0
1
0
-1
454
1
-50
-501454-101001-1-10
   > Long-term Assets 
0
0
0
88,232
47,216
42,874
26,346
23,329
22,930
22,708
22,280
13,361
13,36122,28022,70822,93023,32926,34642,87447,21688,232000
       Property Plant Equipment 
908
711
841
713
344
296
2,827
2,562
2,237
1,887
1,529
1,172
1,1721,5291,8872,2372,5622,827296344713841711908
       Goodwill 
0
20,059
0
20,059
20,059
20,059
18,059
18,059
18,059
18,259
18,059
11,968
11,96818,05918,25918,05918,05918,05920,05920,05920,059020,0590
       Long Term Investments 
0
0
0
0
10
3,878
0
0
0
0
0
0
0000003,878100000
       Intangible Assets 
23
0
86,367
87,213
47,535
18,514
5,299
2,475
2,472
2,472
2,472
0
02,4722,4722,4722,4755,29918,51447,53587,21386,367023
       Long-term Assets Other 
0
0
0
88,232
-895
42,874
26,346
0
0
0
0
0
0000026,34642,874-89588,232000
> Total Liabilities 
9,844
30,028
26,437
31,011
28,199
17,848
20,432
17,470
20,121
20,816
20,469
26,194
26,19420,46920,81620,12117,47020,43217,84828,19931,01126,43730,0289,844
   > Total Current Liabilities 
6,357
12,920
10,606
12,417
18,842
8,393
6,199
6,047
7,063
7,149
11,130
18,337
18,33711,1307,1497,0636,0476,1998,39318,84212,41710,60612,9206,357
       Short-term Debt 
91
78
69
106
130
450
0
0
0
0
0
0
000000450130106697891
       Short Long Term Debt 
91
78
69
106
130
450
734
1,502
2,953
1,003
1,447
7,297
7,2971,4471,0032,9531,502734450130106697891
       Accounts payable 
4,096
6,676
6,362
9,246
5,956
4,145
3,672
2,762
2,832
3,449
2,458
5,247
5,2472,4583,4492,8322,7623,6724,1455,9569,2466,3626,6764,096
       Other Current Liabilities 
901
949
1,998
1,529
10,727
3,053
136
495
807
504
2,004
3,128
3,1282,0045048074951363,05310,7271,5291,998949901
   > Long-term Liabilities 
0
0
0
18,594
9,357
9,454
14,233
11,423
13,058
13,667
9,339
7,857
7,8579,33913,66713,05811,42314,2339,4549,35718,594000
       Capital Lease Obligations 
0
0
0
0
0
0
2,446
2,257
1,899
981
645
507
5076459811,8992,2572,446000000
       Long-term Liabilities Other 
0
0
0
204
-1
0
0
5,090
6
4,048
1,741
1,739
1,7391,7414,04865,09000-1204000
       Deferred Long Term Liability 
0
67,873
0
67,122
27,461
18,513
5,298
2,472
2,472
2,472
0
0
002,4722,4722,4725,29818,51327,46167,122067,8730
> Total Stockholder Equity
7,888
121,971
102,798
94,089
49,874
45,402
17,197
29,036
32,942
22,270
14,805
-8,930
-8,93014,80522,27032,94229,03617,19745,40249,87494,089102,798121,9717,888
   Common Stock
5,171
10,136
10,138
11,761
12,674
13,344
15,329
19,579
22,999
0
0
0
00022,99919,57915,32913,34412,67411,76110,13810,1365,171
   Retained Earnings 
-15,325
-7,699
-19,409
-22,671
-59,071
-9,399
-33,728
1,089
-5,937
-19,562
-52,716
-46,197
-46,197-52,716-19,562-5,9371,089-33,728-9,399-59,071-22,671-19,409-7,699-15,325
   Accumulated Other Comprehensive Income 000000000000
   Capital Surplus 000000000000
   Treasury Stock000000000000



6.4. Balance Sheets

Currency in EUR. All numbers in thousands.




6.5. Cash Flows

Currency in EUR. All numbers in thousands.




6.6. Income Statements

Currency in EUR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,793
Cost of Revenue-513
Gross Profit1,2801,280
 
Operating Income (+$)
Gross Profit1,280
Operating Expense-18,281
Operating Income-16,488-17,001
 
Operating Expense (+$)
Research Development5,144
Selling General Administrative2,660
Selling And Marketing Expenses-
Operating Expense18,2817,804
 
Net Interest Income (+$)
Interest Income484
Interest Expense-177
Other Finance Cost-136
Net Interest Income171
 
Pretax Income (+$)
Operating Income-16,488
Net Interest Income171
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-23,553-16,488
EBIT - interestExpense = -177
-23,931
-23,754
Interest Expense177
Earnings Before Interest and Taxes (EBIT)--23,376
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-23,553
Tax Provision-377
Net Income From Continuing Ops-23,930-23,930
Net Income-23,931
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--171
 

Technical Analysis of Onxeo SA
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Onxeo SA. The general trend of Onxeo SA is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Onxeo SA's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Onxeo SA Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Onxeo SA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: .

The bearish price targets are: 0.129 > 0.1198 > 0.119.

Know someone who trades $C4X? Share this with them.👇

Onxeo SA Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Onxeo SA. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Onxeo SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Onxeo SA. The current macd is 0.02436742.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Onxeo SA price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Onxeo SA. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Onxeo SA price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Onxeo SA Daily Moving Average Convergence/Divergence (MACD) ChartOnxeo SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Onxeo SA. The current adx is 51.13.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Onxeo SA shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Onxeo SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Onxeo SA. The current sar is 0.27654.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Onxeo SA Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Onxeo SA. The current rsi is 61.23. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Onxeo SA Daily Relative Strength Index (RSI) ChartOnxeo SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Onxeo SA. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Onxeo SA price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Onxeo SA Daily Stochastic Oscillator ChartOnxeo SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Onxeo SA. The current cci is 72.08.

Onxeo SA Daily Commodity Channel Index (CCI) ChartOnxeo SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Onxeo SA. The current cmo is 21.73.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Onxeo SA Daily Chande Momentum Oscillator (CMO) ChartOnxeo SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Onxeo SA. The current willr is -51.15658363.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Onxeo SA is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Onxeo SA Daily Williams %R ChartOnxeo SA Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Onxeo SA.

Onxeo SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Onxeo SA. The current atr is 0.02940918.

Onxeo SA Daily Average True Range (ATR) ChartOnxeo SA Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Onxeo SA. The current obv is -321,998.

Onxeo SA Daily On-Balance Volume (OBV) ChartOnxeo SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Onxeo SA. The current mfi is 45.86.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Onxeo SA Daily Money Flow Index (MFI) ChartOnxeo SA Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Onxeo SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-07-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-07 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-10 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-11 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-14 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-15 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-16 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-18 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-21 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-24 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-29 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-30 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-08-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-21 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-08-22 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-26 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-27 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-08-28 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-29 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-05 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-08 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-09 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-09-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-15 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-16 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-09-17 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-18 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-22 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-09-23 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-09-24 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-26 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-09-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-01 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-10-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-03 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-10-06 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-13 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-10-14 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-10-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-21 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-24 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-10-27 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-28 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-10-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-30 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-31 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-11-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-11-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-11-06 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-11-07 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-11-10 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-11-11 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-11-12 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-11-13 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-11-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Onxeo SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Onxeo SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.233
Ma 20Greater thanMa 500.101
Ma 50Greater thanMa 1000.075
Ma 100Greater thanMa 2000.067
OpenGreater thanClose0.102
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Onxeo SA with someone you think should read this too:
  • Are you bullish or bearish on Onxeo SA? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Onxeo SA? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Onxeo SA

I send you an email if I find something interesting about Onxeo SA.


Comments

How you think about this?

Leave a comment

Stay informed about Onxeo SA.

Receive notifications about Onxeo SA in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.